October 10 2018

MedDay attends the 34th congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Berlin, Germany

September 27 2018

MedDay attends the 31st congress of "Association des Neurologues Libéraux de Langue française" (ANLLF) in Rennes, France

June 16 2018

MedDay attends the 4th congress of the European Academy of Neurology (EAN) in Lisbon, Portugal

May 30 2018

MedDay attends the 2018 Consortium of Multiple Sclerosis Centers (CMSC) Meeting in Nashville, Tennessee

April 21 2018

MedDay attends the 70th annual American Academy of Neurology (AAN) Meeting in Los Angeles, California

April 10 2018

MedDay attends les "Journées de Neurologie de Langue Française" (JNLF) 2018 in Bordeaux, France

February 01 2018

MedDay attends the third annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2018 in San Diego, California

October 16 2017

MedDay to Participate in the 7th Joint ECTRIMS – ACTRIMS Meeting in Paris, France

September 18 2017

MedDay Pharmaceuticals GmbH to participate at the 90th Congress of the German Society of Neurology in Leipzig, Germany

May 25 2016

MedDay attends European Academy of Neurology 2016 and presents extension phase results of the MS-SPI trial

April 27 2015

MedDay to webcast results of its pivotal Phase III study of MD1003 in patients with Progressive Multiple Sclerosis